A recent article discusses the advent of synthetic biology, the creation of entirely artificial life forms through DNA sequencing. With respect to intellectual property, this raises several questions, including the applicability of current patent law to living organisms, as opposed to the processes used to create those organisms or the uses of those organisms.
Jeffrey Waldin has nearly twenty years of experience in regulatory compliance, with an emphasis on the design and implementation of office processes and information systems. He has been involved with AUTM since 2003, and acted as an early stage judge from the AUTM Venture Forum competition for the last two years. He has also been involved with SRA since 2003, and has served on the Education and Professional Development Committee for the past two years. Jeffrey has been with InfoEd Global for twelve years, for the last nine as the Product Manager responsible for intellectual property and conflict of interest management.